Research Article
Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma
Table 1
Demographic characteristics.
| | Characteristic | Melanoma cases | Controls | P-value |
| | All subjects—no | 327 | 119 | |
| | Sex—no (%) | | | | | Male | 162 (49.5%) | 41 (34.5%) |
.0047 | | Female | 165 (50.5%) | 78 (65.6%) | | Age—yr (median (interquartile range)) | 53 (41–66) | 56 (46–66) | | | Family history melanoma—no (%) | 51 (15.8%) | 11 (9.5%) | .0926 | | Skin Color—no (%) | | | | | Light | 287 (88.9%) | 49 (69.0%) |
<.0001 | | Dark | 36 (11.1%) | 22 (31.0%) | | Number of moles on back (median (interquartile range)) | 10 (4–29.5) | 5 (1–12) | | | Current medication use—no (%) | 217 (66.4%) | 91 (76.5%) | .0413 | | Past medication use—no (%) | 106 (32.9%) | 46 (40.0%) | .1918 | | Comorbidities—no (%) | 168 (50.9%) | 70 (58.3%) | .1634 | | Cardiovascular disease—no (%) | 37 (8.2%) | 9 (7.5%) | .7965 | | Musculoskeletal pain—no (%) | 22 (4.9%) | 18 (15.0%) | .0001 |
|
|
SD Standard deviation. P-values for categorical variables are from Mantel-Haenszel χ2 test.
|
